User profiles for Iñigo Ojanguren

Iñigo Ojanguren

Vall d'hebron university hospital
Verified email at vallhebron.cat
Cited by 751

[HTML][HTML] Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated international task force …

…, A Moskowitz, RA Oeckler, I Ojanguren… - European …, 2020 - Eur Respiratory Soc
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …

Hypersensitivity pneumonitis: challenges in diagnosis and management, avoiding surgical lung biopsy

F Morell, A Villar, I Ojanguren… - … in respiratory and …, 2016 - thieme-connect.com
This review presents an update of the currently available information related to hypersensitivity
pneumonitis, with a particular focus on the contribution of several techniques in the …

Long‐term outcomes in chronic hypersensitivity pneumonitis

I Ojanguren, F Morell, MA Ramón, A Villar, C Romero… - Allergy, 2019 - Wiley Online Library
Introduction The objective of this study was to analyze mortality, possible predictors of long‐term
survival, and health‐related quality of life of a large chronic hypersensitivity pneumonitis …

European Respiratory Society guidelines for the diagnosis of asthma in adults

R Louis, I Satia, I Ojanguren, F Schleich… - European …, 2022 - Eur Respiratory Soc
Although asthma is very common, affecting 5–10% of the population, the diagnosis of
asthma in adults remains a challenge in the real world, which results in both over- and under-…

Diagnosis of occupational hypersensitivity pneumonitis

F Morell, I Ojanguren, MJ Cruz - Current Opinion in Allergy and …, 2019 - journals.lww.com
Diagnosis of OHP should be made with a thorough clinical history of the symptoms and
clinical signs as well as a meticulous review, if possible by an expert, of possible exposures in …

[HTML][HTML] Do low molecular weight agents cause more severe asthma than high molecular weight agents?

…, M Sánchez-Ortiz, FJ González-Barcala, I Ojanguren… - PLoS …, 2016 - journals.plos.org
Introduction The aim of this study was to analyse whether patients with occupational asthma
(OA) caused by low molecular weight (LMW) agents differed from patients with OA caused …

EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities

…, L Klimek, C Lemiere, P Nair, I Ojanguren… - Allergy, 2022 - Wiley Online Library
Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires both the
demonstration of IgE‐sensitization to aeroallergens and the causative role of this sensitization …

Is asthma a risk factor for COVID-19? Are phenotypes important?

X Muñoz, F Pilia, I Ojanguren… - ERJ Open …, 2021 - Eur Respiratory Soc
Asthma is a major health problem all over the world [1]. Since severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is a respiratory pathogen, it is important to quantify the …

YKL-40 and KL-6 levels in serum and sputum of patients diagnosed with hypersensitivity pneumonitis

S Sánchez-Díez, X Munoz, I Ojanguren… - The Journal of Allergy …, 2022 - Elsevier
Background YKL-40 (chitinase 3-like-1) and Krebs von den Lungen-6 (KL-6) are 2 promising
biomarkers that may have an important role in the management of interstitial lung diseases …

[HTML][HTML] Risk factors for the development of bronchiectasis in patients with asthma

D Ma, MJ Cruz, I Ojanguren, C Romero-Mesones… - Scientific Reports, 2021 - nature.com
Though asthma and bronchiectasis are two different diseases, their coexistence has been
demonstrated in many patients. The aim of the present study is to compare the characteristics …